SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CNS Pharmacology

» Start this Course
(Practice similar questions for free)
Question:

Selegine pharmacokinetics

Author: Suzuki



Answer:

Selegiline administered as the transdermal patch may produce less inhibition of gut and hepatic MAO at low doses because it avoids first-pass metabolism.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki